Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Avicenna Alliance Task Forces

APAC Task Force International Affairs Working Group APAC Task Force Mission: Nurture a community of collaboration among Regulators, Industry, and Academia in the APAC region to advance in silico methods, best practices, and policies for Regulatory Science and Innovation Artificial intelligence (AI) Task Force Research & Technology Working Group Artificial intelligence (AI) Task Force Mission: Engage in all AA activities related to AI Cancer & In Silico Oncology Task Force Research & Technology Working Group Cancer & In Silico Oncology Task Force Mission: Accelerate, optimize and personalize cancer treatment through the development, clinical validation and clinical translation of in silico methods Clinical Deployment Task Force In Silico Application Working Group Clinical Deployment Task Force Mission: Promote use of in silico medicine from product development to clinical practice CMC Application Task Force In Silico Application Working Group CMC Application Task Force Mission: Promote use of in silico solutions in CMC throughout product lifecycle EMA Collaboration Task Force Policy Development Working Group EMA Collaboration Task Force Mission: Closely collaborate with the European Medicine Agency (EMA) to inform them about the progress of in silico methods and learn about EMA requirements to accept digital evidence Global Harmonization Task Force International Affairs Working Group Global Harmonization Task Force Mission: Inform and educate regulatory agencies around the world to ensure harmonized adoption of in silico methods Good Simulation Practice (GSP) Task Force Policy Development Working Group Good Simulation Practice (GSP) Task Force Mission: Drafting a Good Simulation Practice document widely recognized and accepted similar to the Good Clinical Practice Horizon Europe Task Force Research & Technology Working Group Horizon Europe Task Force Mission: Monitor, influence & inform on Horizon Europe Funding In Silico Liabilities Task Force In Silico Application Working Group In Silico Liabilities Task Force Mission: Accelerate, optimize and personalize cancer treatment through the development, clinical validation and clinical translation of in silico methods Nonclinical Application Task Force In Silico Application Working Group Nonclinical Application Task Force Mission: Promote use of in silico solutions to conduct smarter (3R’s) nonclinical studies Notified Bodies (NB) Task Force Policy Development Working Group Notified Bodies (NB) Task Force Mission: Systematic engagement with NBs to advance in silico trials in Europe Pharmaceutical Strategy (Pharma) Task Force Policy Development Working Group Pharmaceutical Strategy (Pharma) Task Force Mission: Accelerate Adoption by Healthcare Stakeholders of In Silico Medicine for Bringing New Medicine to Patients Public & Patient Involvement (PPI) Task Force Policy Development Working Group Public & Patient Involvement (PPI) Task Force Mission: Empower the public & patients to understand the potential of in silico medicine, improve healthcare creating ‘user demand’, encourage greater funding and drive broader clinical and regulatory adoption for enhanced impact Tissue Characterization Task Force Research & Technology Working Group Tissue Characterization Task Force Mission: Create a data base of biological tissue properties with Certificate of Birth UK In Silico Regulatory Innovation Task Force International Affairs Working Group UK In Silico Regulatory Innovation Task Force Mission: Nurture a cross-sector UK in silico trials community for regulatory science & innovation to produce evidence and harmonize standards in the UK accelerating in silico adoption in regulations

NEWS

News Avicenna at eHealth Stakeholders group meeting

Avicenna at eHealth Stakeholders group meeting

Very interesting exchanges yesterday, during the meeting of the e-health stakeholders group organized by the European Commission.

News Avicenna Alliance at University of Toulouse

Avicenna Alliance at University of Toulouse

On February 9, Noemie Dubruel, active member of the Avicenna Alliance as a doctoral student in Droit de la santé et de la recherche médicale at the University of Toulouse 1 Capitole and Thierry Marchal spoke at the Consortium Santé in silico 6 on synthetic data and simulation in the service of clinical research, organized by Nicolas Savy.

News Abimed is a new Avicenna Partner!

Abimed is a new Avicenna Partner!

We are delighted to welcome Abimed as a new Avicenna Partner.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry